首页> 外文会议>Keio International Symposia for Life Sciences and Medicine >Design and Modification of Nanoparticles for Blood Substitutes
【24h】

Design and Modification of Nanoparticles for Blood Substitutes

机译:血液替代品纳米粒子的设计与改性

获取原文

摘要

We have been developing the technology of stabilized and functionalized nanoparticles such as liposomes for 20 years. When phospholipids and cholesterol are dispersed into an aqueous solution, they spontaneously assemble to form vesicles with a bimolecular (bilayer) membrane. There are many parameters, such as size, size distribution, lamellarity (the number of bilayer membranes), membrane fluidity, surface charge, surface modification, membrane permeability, that characterize liposomes. They can be adjusted as need dictates to allow for changing encapsulation of functional molecules, release triggered by external stimuli, conjugation of functional sites on the surface, rolling or adhesion properties of liposomes, and control of blood circulation time. On the other hand, we have to consider their physical and chemical stability during storage or blood circulation. Surface modification with poly-oxyethylene (POE) chains is one of the most effective ways to impart such stabilization.
机译:我们一直在开发稳定和官能化纳米颗粒的技术,例如脂质体20年。当磷脂和胆固醇分散到水溶液中时,它们自发地组装以形成囊泡,用双分子(双层)膜形成囊泡。存在许多参数,例如尺寸,尺寸分布,层状膜的层状(双层膜的数量),膜流动性,表面电荷,表面改性,膜渗透性,表征脂质体。它们可以调整,因为需要调整,以便允许改变功能分子的封装,通过外部刺激释放释放,功能位点在表面,脂质体的表面,滚动或粘附性质的缀合,以及对血液循环时间的控制。另一方面,我们必须在储存或血液循环期间考虑它们的物理和化学稳定性。用聚氧乙烯(POE)链的表面改性是赋予这种稳定性最有效的方法之一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号